Thursday, October 11, 2018, 9:00 AM - 4:00 PM, Indianapolis Marriott East, Indianapolis, IN


The public health conference provides a forum in which people from diverse perspectives can work together to achieve a shared goal of addressing Indiana’s most pressing public health issues. The theme for the 2018 conference is harm reduction, a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. Harm reduction services and policies are effective, humane, equitable, and life-saving strategies that are vital to any comprehensive response to the opioid epidemic.

The conference will focus on:

• The life-saving and cost-saving impact of harm reduction services
• Evidence-based and effective harm reduction services and policies, including syringe exchange services, housing first, and law enforcement diversion programs
• How to plan and implement harm reduction services
• National, state, and local examples of harm reduction services and policies
• Engaging in cross-sector collaboration
• Addressing attitudes about and relationships to drugs and drug users
• Recognizing and reducing health, social, and systemic inequalityThe conference welcomes self-advocates; students; people with opioid use disorder; people living in recovery; and professionals in public health, health care (including emergency medicine, family practice, internal medicine, nursing, pain management, and pharmacy), behavioral health, peer recovery, state and local government, public safety and law enforcement, academia, housing/homelessness, policy and law, social services, and other fields to join us.

  Click here for more information.

  
  
  
  Objectives
  At the conclusion of this activity, participants should be able to:
  
  
  1. Develop and apply stigma-reducing behavior;
  2. Identify 2-3 ways they can build trust and strengthen their relationships with patients who have opioid use disorder;
  3. Identify 2-3 harm reduction strategies that can reduce overdose, risk, and death;
  4. Use MAT to treat people with opioid use disorder; and
  5. Identify 2-3 recovery approaches.
  
  
  Registration

  Online registration is now closed. If you wish to attend, you may register on-site at the conference. Registration begins at 8 a.m.

  General Attendance: $50, Student: $25 

  In addition to the conference, there will be additional opportunities for learning and networking. See below for a brief summary of the additional opportunities. You may register for them when registering for the conference by visiting the "Register" tab.

  October 10, 2018: Pre-Conference Workshop: Harm Reduction and Syringe Service Program Workshop, 8:30 a.m. - 12:30 p.m., Indianapolis Marriott East, Fee: $30

  This workshop provides an opportunity for local public health professionals and their community partners to explore the process of engaging their communities in discussions and planning around harm reduction and syringe service programs (SSPs). Public health and harm reduction experts will provide an interactive learning experience for participants. Counties at all stages of SSP development are encouraged to attend. Capacity: 50

  Workshop participants will:

  • Explore personal and community beliefs about harm reduction and SSPs;
  • Identify barriers and facilitators to SSPs they have encountered in their communities;
  • Discuss what has worked and what hasn't in Indiana countis with active and discontinued SSPs
  • Learn about options for housing, equipping, and staffing an SSP; and
  • Create action steps for moving forward with harm reduction and SSP development in a county or municipality.

  Training on the Administration of Naloxone

  Thanks to Indiana Senate Bill 406, (AKA Aaron’s Law) family members, friends, and community members may obtain naloxone without a prescription, and may legally administer it to persons experiencing an opioid-related overdose.Training on the administration of naloxone will be provided at the conference. Free naloxone kits will be given to attendees who either: 1) have loved ones and friends with opiate dependence, or 2) come in frequent contact with persons in the community at risk for opiate-related overdose. 
  
  
  Accreditation

  The Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  The Indiana University School of Medicine designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  
  
  Additional Information

  For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or cme@iu.edu. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.
  

  
  
  Credits
  AMA PRA Category 1 Credits™ (7.00 hours), Non-Physician Attendance (7.00 hours)
  

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by the Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

To view any relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity, please click the names below.  All conflicts were resolved in accordance with ACCME.